Bowman and Brooke Logo


August 27, 2020

"Medical Products to Combat the COVID-19 Crisis" Featured in DRI's In-House Defense Quarterly

Liability immunity emanating from different federal authorities may protect companies involved in designing, manufacturing, testing, marketing, distributing, or using medical products.

Related Topics
legal alert icon

In mere months, the spread of COVID-19 caused by the novel coronavirus (SARSCoV-2) has caused a world health crisis unparalleled in the last hundred years. In early March, the World Health Organization declared COVID-19 a global pandemic, emphasizing that it is “not just a public health crisis[;] it is a crisis that will touch every sector.” That prediction was accurate. Among the sectors affected in the United States is the court system, with an upward trend in lawsuits related to the novel coronavirus that is expected to continue.

Continue reading the full article, "Medical Products to Combat the COVID-19 Crisis: Potential Defenses to Product Liability Claims" authored by Susan Burnett, Patrick Cleary and Daniel Rock here.


Related Practices